Encompass Health [EHC] vs Ensign Group [ENSG] Detailed Stock Comparison
Encompass Health
NYSE
Loading...
Ensign Group
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Encompass Health wins in 16 metrics, Ensign Group wins in 4 metrics, with 0 ties. Encompass Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Encompass Health | Ensign Group | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.02 | 31.83 | Encompass Health |
| Price-to-Book Ratio | 5.45 | 4.98 | Ensign Group |
| Debt-to-Equity Ratio | 86.97 | 100.93 | Encompass Health |
| PEG Ratio | 0.97 | 1.82 | Encompass Health |
| EV/EBITDA | 12.32 | 23.81 | Encompass Health |
| Profit Margin (TTM) | 9.22% | 7.00% | Encompass Health |
| Operating Margin (TTM) | 17.77% | 8.46% | Encompass Health |
| EBITDA Margin (TTM) | 17.77% | 8.46% | Encompass Health |
| Return on Equity | 24.72% | 17.54% | Encompass Health |
| Return on Assets (TTM) | 9.18% | 5.30% | Encompass Health |
| Free Cash Flow (TTM) | $360.30M | $188.95M | Encompass Health |
| Dividend Yield | 0.55% | 0.18% | Encompass Health |
| 1-Year Return | 28.81% | 20.36% | Encompass Health |
| Price-to-Sales Ratio (TTM) | 2.19 | 2.19 | Encompass Health |
| Enterprise Value | $15.81B | $11.67B | Encompass Health |
| EV/Revenue Ratio | 2.79 | 2.53 | Ensign Group |
| Gross Profit Margin (TTM) | 43.01% | 16.19% | Encompass Health |
| Revenue per Share (TTM) | $57 | $81 | Ensign Group |
| Earnings per Share (Diluted) | $5.13 | $5.51 | Ensign Group |
| Beta (Stock Volatility) | 0.80 | 0.93 | Encompass Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Encompass Health vs Ensign Group Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Encompass Health | 0.32% | -1.79% | -1.86% | 3.54% | 27.83% | 34.59% |
| Ensign Group | 1.04% | 3.31% | 1.78% | 20.09% | 42.20% | 33.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Encompass Health | 28.81% | 162.80% | 128.33% | 299.42% | 754.91% | 663.56% |
| Ensign Group | 20.36% | 113.78% | 205.45% | 790.55% | 3,703.00% | 4,201.46% |
News Based Sentiment: Encompass Health vs Ensign Group
Encompass Health
News based Sentiment: POSITIVE
Encompass Health delivered a strong Q2 earnings report, received positive analyst coverage with increased price targets, and continues to execute its expansion strategy. While some insider selling and short-term stock declines occurred, the overall narrative is positive, indicating continued growth potential and investor confidence.
Ensign Group
News based Sentiment: POSITIVE
October proved to be a very positive month for Ensign Group, with a Zacks upgrade, all-time high stock price, strong earnings beat, and positive guidance. While there was some insider selling and institutional adjustments, the overall narrative is one of growth and financial strength, making it a significant month for investors.
Performance & Financial Health Analysis: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Market Information | ||
| Market Cap | $12.63B | $10.12B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 581,540 | 291,431 |
| 90 Day Avg. Volume | 643,327 | 354,167 |
| Last Close | $123.62 | $177.22 |
| 52 Week Range | $87.85 - $127.86 | $118.73 - $179.11 |
| % from 52W High | -3.32% | -1.06% |
| All-Time High | $127.86 (Sep 23, 2025) | $179.11 (Oct 06, 2025) |
| % from All-Time High | -3.32% | -1.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.19% |
| Quarterly Earnings Growth | 0.25% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.07% |
| Operating Margin (TTM) | 0.18% | 0.08% |
| Return on Equity (TTM) | 0.25% | 0.18% |
| Debt to Equity (MRQ) | 86.97 | 100.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.60 | $35.23 |
| Cash per Share (MRQ) | $0.98 | $7.30 |
| Operating Cash Flow (TTM) | $1.11B | $462.89M |
| Levered Free Cash Flow (TTM) | $261.28M | $30.01M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.55% | 0.18% |
| Last 12-Month Dividend | $0.66 | $0.30 |
Valuation & Enterprise Metrics Analysis: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.02 | 31.83 |
| Forward P/E | 25.78 | 28.57 |
| PEG Ratio | 0.97 | 1.82 |
| Price to Sales (TTM) | 2.19 | 2.19 |
| Price to Book (MRQ) | 5.45 | 4.98 |
| Market Capitalization | ||
| Market Capitalization | $12.63B | $10.12B |
| Enterprise Value | $15.81B | $11.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.79 | 2.53 |
| Enterprise to EBITDA | 12.32 | 23.81 |
| Risk & Other Metrics | ||
| Beta | 0.80 | 0.93 |
| Book Value per Share (MRQ) | $22.60 | $35.23 |
Financial Statements Comparison: Encompass Health vs Ensign Group
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Revenue/Sales | $1.46B | $1.23B |
| Cost of Goods Sold | $824.50M | $1.03B |
| Gross Profit | $630.90M | $198.79M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $267.00M | $103.90M |
| EBITDA | $349.60M | $140.17M |
| Pre-Tax Income | $238.60M | $112.36M |
| Income Tax | $41.60M | $27.89M |
| Net Income (Profit) | $196.50M | $84.47M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Cash & Equivalents | $95.80M | $282.67M |
| Total Current Assets | $910.90M | $986.39M |
| Total Current Liabilities | $856.00M | $705.21M |
| Long-Term Debt | $2.54B | $1.91B |
| Total Shareholders Equity | $2.94B | $1.93B |
| Retained Earnings | $930.80M | $1.50B |
| Property, Plant & Equipment | $3.94B | $2.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EHC | ENSG |
|---|---|---|
| Operating Cash Flow | $289.30M | $97.90M |
| Capital Expenditures | $-163.10M | $-42.93M |
| Free Cash Flow | $125.50M | $29.29M |
| Debt Repayment | $-80.00M | $-1.01M |
| Common Stock Repurchase | $-32.10M | $-10.79M |
Short Interest & Institutional Ownership Analysis
| Metric | EHC | ENSG |
|---|---|---|
| Shares Short | 1.46M | 1.84M |
| Short Ratio | 2.25 | 5.40 |
| Short % of Float | 0.02% | 0.04% |
| Average Daily Volume (10 Day) | 581,540 | 291,431 |
| Average Daily Volume (90 Day) | 643,327 | 354,167 |
| Shares Outstanding | 100.78M | 57.44M |
| Float Shares | 99.22M | 55.24M |
| % Held by Insiders | 0.01% | 0.03% |
| % Held by Institutions | 0.97% | 0.98% |
Dividend Analysis & Yield Comparison: Encompass Health vs Ensign Group
| Metric | EHC | ENSG |
|---|---|---|
| Last 12-Month Dividend | $0.66 | $0.30 |
| Last 12-Month Dividend Yield | 0.55% | 0.18% |
| 3-Year Avg Annual Dividend | $3.68 | $0.26 |
| 3-Year Avg Dividend Yield | 1.66% | 0.05% |
| 3-Year Total Dividends | $11.04 | $0.78 |
| Ex-Dividend Date | Apr 01, 2025 | Sep 30, 2025 |